TAVI Newsletter

Sign up to TAVI news and keep up to date with the latest research on and progress in aortic stenosis (AS). From the latest cardiovascular industry developments through to daily healthcare practice. Each features a spotlight and clinical insights on key topics of the day.

Stay informed with our newsletter

By providing your personal information, you agree to allow Edwards Lifesciences and its agents to use this information to communicate with you in the future, including information about services, events, and programs. Edwards Lifesciences and its agents will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Edwards Lifesciences and its agents, Edwards Lifesciences will use your information in accordance with the Edwards privacy policy.

As a subscriber you will benefit from

Panel discussions

Involving leading cardiologists debating the latest developments in TAVI and AS management.

Patient materials

To support your consultations. Including information leaflets, symptom trackers and tactile models that will help explain aortic stenosis and potential treatment options.

Essential publications

Highlighting the latest clinical trial and real-world evidence in AS management. Also featuring updates from the PARTNER 3 Trial on SAPIEN 3 TAVI.1

Education materials

Including guideline tools and animated videos of TAVI procedures. Information brochures covering subjects such as TAVI durability, and hospital resource optimisation.

Congress updates

Keeping you informed of all the major talking points from the latest congress events.

Check our latest articles

View all articles

References:

1 Mack MJ, Leon MB, Thourani VH, et al. N Engl J Med 2019;380(18):1695-1705.

Medical device for professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

PP--EU-0780 v2.0